Completed NA INTERVENTIONAL 2-arm NCT01232231

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus in the Outpatient Setting: a Randomized Controlled Study

Sponsor: Alberta Health services

Conditions Methicillin-resistant Staphylococcus Aureus

Interventions Education pharmacological decolonization treatment

Updated 6 times since 2017 Last updated: Feb 14, 2013 Started: Jul 31, 2010 Primary completion: Apr 30, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01232231, this NA trial focuses on Methicillin-resistant Staphylococcus Aureus and remains completed. Sponsored by Alberta Health services, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Nov 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alberta Health services
Joseph Kim

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada